SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
food and drug administration
‘Open, Shameless Grift’: Right Before FDA Ruling on Vapes, Big Tobacco Company Gave $5 Million to a Trump Super PAC
"In the Trump administration, money beats MAHA every time."
May 21, 2026
It was already known that President Donald Trump pressured top health officials to allow flavored vapes to hit the market after being leaned on by Big Tobacco executives earlier this month.
But The New York Times has revealed that the decision came just over a week after a massive super political action committee (PAC) donation from one of the cigarette companies looking to have the regulations lifted.
Kenneth Vogel and Christina Jewett reported for the Times that on April 30, a subsidiary of the tobacco company Reynolds Americans—which owns Camel and Lucky Strike cigarettes—donated $5 million to the Trump-backed super PAC MAGA Inc., according to a financial report filed on Wednesday. It brought the total amount donated to the PAC up to $8 million.
The donation came just two days before tobacco industry executives held their sit-down with Trump at his golf club in Jupiter, Florida, where they told the president they were displeased with the FDA's ban on flavored vapes, which was enacted in light of evidence that they were driving an epidemic of youth vaping.
According to a youth survey by the Centers for Disease Control and Prevention (CDC), the vast majority of middle- and high school-aged e-cigarette users prefer fruit and candy-flavored vapes.
The Times reported earlier this month that immediately after receiving an earful from executives at Reynolds and Philip Morris owner Altria, Trump rang Secretary of Health and Human Services Robert F. Kennedy, Jr., and Centers for Medicare and Medicaid Services head Mehmet Oz to complain about the FDA's ban on e-cigarettes.
In the days that followed the meeting, Trump reportedly berated then-FDA Commissioner Marty Makary, who hesitated to reverse the policy due to the potential impact on children. Makary ultimately resigned less than a week later, along with RFK Jr.'s chief spokesperson, Rich Danker, citing disagreement about the e-cigarette policy change as the ultimate reason.
Within a week of the meeting with executives, the FDA announced it was dropping the ban on fruit-flavored vapes and authorizing the sale of mango and blueberry flavors by the Los Angeles-based company Glas Inc., which could pave the way for major cigarette makers to launch their own products on store shelves. It also allowed companies to add greater amounts of nicotine to pouches, which smokers often use in order to quit the habit.
Kush Desai, a spokesperson for the White House, told the Times that Reynolds' $5 million donation to the MAGA Inc. PAC had nothing to do with the administration's sudden shift in policy surrounding flavored vapes. He said "the only guiding factor behind the Trump administration’s health policymaking is gold standard science," as well as "recent evidence that has found [vapes] can help adults quit smoking.”
A spokesperson for MAGA Inc. said his organization “is pleased to accept legal contributions from those who agree with President Trump’s America First agenda and his goal to make America great again.”
The $5 million donation is far from the only contribution Big Tobacco has made to Trump. As Common Dreams reported earlier this month:
Trump, who ran in 2024 on a pledge to “save vaping” as part of an effort to appeal to young voters, has raked in huge sums of money from the tobacco industry. According to data from OpenSecrets, his inaugural committee took over $3 million from vaping special interests, including $1.25 million from the Vapor Technology Association, and $1 million apiece from Altria and Breeze Smoke.
Altria, which owns Marlboro maker Philip Morris, and Reynolds American, which owns Lucky Strike and Camel, have also offered donations to Trump’s $400 million White House ballroom project. Reynolds, the biggest producer of menthol cigarettes, also gave $10 million to the super PAC backing Trump in 2024.
The Times also reported on Wednesday that a Reynolds executive was invited to a dinner hosted by Trump at the White House in October for donors who gave $2.5 million or more.
The open, shameless grift.www.nytimes.com/2026/05/20/u...
[image or embed]
— Wajahat Ali (@wajali.bsky.social) May 21, 2026 at 1:21 AM
Critics described the $5 million donation as effectively a legal "bribe" to Trump and the latest example of the White House's "open, shameless grift."
It comes amid what seem to be endless reports of blatant self-dealing by Trump allies, most recently exemplified by the Trump-controlled Department of Justice's settlement of a lawsuit from Trump against the Internal Revenue Service, which handed the president $1.8 billion in taxpayer funds that he plans to disperse to his allies as part of a so-called “weaponization fund,” which critics have dubbed a “slush fund.”
It's also the latest example of Trump appearing to take actions in direct service of rich corporate donors—particularly in the fossil fuel, artificial intelligence, and cryptocurrency industries—or members of his family or personal inner circle.
Rep. Seth Magaziner (D-RI) also described the FDA's policy change on vaping as a betrayal by the administration's overseer, Kennedy. Though the HHS secretary has built his brand on pledges to "Make America Healthy Again" by decoupling corporate interests from health policy, he has been accused of bending to industry pressure on everything from food regulation to cancer-causing pesticides.
"In the Trump administration," Magaziner said, "money beats MAHA every time."
Keep ReadingShow Less
'Temporary Relief Isn't Enough,' Advocates Warn After Supreme Court Blocks Abortion Pill Restrictions
"We are relieved that access to mifepristone remains protected for now, but this should never have been on the table in the first place," said one campaigner.
May 14, 2026
While welcoming that the US Supreme Court on Thursday blocked restrictions on dispensing mifepristone—a medication commonly used in abortion and miscarriage care—as a legal battle over it moves forward, rights advocates also continued to sound the alarm about attacks on reproductive freedom and argue that "temporary relief isn't enough."
At issue is the 2023 Food and Drug Administration (FDA) decision to permanently lift mifepristone's in-person dispensing requirement, which has enabled doctors to serve patients nationwide via telehealth and the mail, as forced pregnancy advocates have intensified the fight for state laws cutting off access to abortion care since the Supreme Court reversed Roe v. Wade in 2022.
Louisiana sued over the FDA's move, and early this month, the notoriously right-wing US Court of Appeals for the 5th Circuit halted the agency's rule easing restrictions. Drugmakers Danco Laboratories and GenBioPro appealed, and Justice Samuel Alito, a member of the high court's right-wing supermajority, issued a one-week stay, which he then extended to Thursday evening.
With that deadline looming, the court ultimately blocked the 5th Circuit's ruling. Alito and Justice Clarence Thomas, another right-winger, dissented.
"While it is good news that, for now, patients can continue to get this safe medication by mail and at pharmacies as they have for more than five years, we all know abortion opponents are continuing their unpopular and baseless attacks," Julia Kaye, senior staff attorney for the ACLU's Reproductive Freedom Project, said in a statement.
"And let's be clear about the Trump administration's role here: When nationwide access to a critical abortion and miscarriage medication was on the line, the Trump administration refused to defend the FDA's action and threw patients under the bus," Kaye noted. "The American people have made clear time and again that they oppose political efforts to interfere with their ability to make their own healthcare decisions—and the ACLU will keep fighting with them every step of the way."
Advocates stressed that the fight is far from over. Monica Simpson, executive director of SisterSong: Women of Color Reproductive Justice Collective, said that her organization "is relieved that the Supreme Court granted the emergency appeal to keep mifepristone accessible through telehealth and mail nationwide."
"This decision ensures that people, especially Black, brown, queer, trans, immigrant, poor, and people living in rural communities who already face barriers to healthcare, can continue accessing essential reproductive care," she noted. "While today's decision prevents immediate harm, people's lives shouldn't hang in the balance between back-and-forth litigation."
"Attacks on mifepristone have never been about safety or medicine," Simpson added. "They are about power and control—about who gets to make decisions about their body, their family, and their future."
All* Above All president Nourbese Flint also welcomed the decision while arguing that "the fact that patients and providers were forced to endure the confusion and disruption of care because of yet another court ruling on whether basic healthcare would remain available is unacceptable."
"This legal whiplash is exhausting, dangerous, and completely disconnected from science," Flint continued. "We know that mifepristone is safe and effective, and has been for over 25 years. People should not have to navigate a week-to-week roller coaster just to find out if they can still access basic healthcare and medication they need."
Serra Sippel, executive director of the Brigid Alliance, which helps people forced to travel for abortion care, similarly said that "we are relieved that access to mifepristone remains protected for now, but this should never have been on the table in the first place. Patients and providers should not be forced to wait on court rulings to know whether people can access critical healthcare."
"The back-and-forth of this case does have a cost. Confusion and uncertainty can delay care, and every day makes a difference. When people are pushed later into pregnancy, care becomes harder to access, more expensive, and many more miles further from home," Sippel explained. "We're seeing this firsthand. Last year, the Brigid Alliance helped 1,879 people travel for abortion care—a 35% increase from the year before—and those numbers will continue to rise as state abortion restrictions force more people to cross state lines for care."
Keep ReadingShow Less
Report Details How Trump Did Big Tobacco’s Bidding on Flavored Vapes Despite Risk to Kids
"Trump could not care less about the health consequences and costs of giving teenagers access to addictive flavored poison if it means his tobacco industry donors can make record profits," said one public health advocate.
May 13, 2026
The resignation of a pair of top health officials in the Trump administration this week has brought to light efforts by the president to help Big Tobacco executives and lobbyists sell addictive flavored e-cigarettes that could be marketed to children.
On Friday, the Food and Drug Administration (FDA) issued new guidance allowing cigarette makers to begin marketing and selling fruit- and candy-flavored vape products on store shelves, which were banned under previous administrations due to evidence that they were driving youth vaping.
The policy was enacted despite the strong opposition of then-FDA Commissioner Marty Makary, who resigned on Tuesday, reportedly because he could not in good conscience support it.
Makary's resignation was followed by the departure of Rich Danker, the chief spokesperson for Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., who similarly warned that the policy "would appeal to children and expose them to nicotine addiction, lung damage, and higher risk of cancer" in a letter addressed to Trump on Wednesday.
Danker did not blame Trump for the policy in his letter; instead, he attributed it to "senior HHS officials in the immediate office of the secretary."
This is despite the fact that The Wall Street Journal reported last week that Trump had personally berated Makary over his hesitation to enact the policy and had signed off on a plan to fire him.
A New York Times report on Wednesday confirms the extent of Trump's direct involvement in strong-arming the FDA into enacting the policy. It found that he pressured higher-ups in HHS to move the policy forward amid a tongue-lashing from tobacco industry lobbyists and executives angry that they could not get in on the highly profitable sale of fruit- and candy-flavored vapes. Despite being illegal and mostly imported to the US from China, these vapes make up about 60% of the total e-cigarette market.
Trump, who ran in 2024 on a pledge to "save vaping" as part of an effort to appeal to young voters, has raked in huge sums of money from the tobacco industry. According to data from OpenSecrets, his inaugural committee took over $3 million from vaping special interests, including $1.25 million from the Vapor Technology Association, and $1 million apiece from Altria and Breeze Smoke.
Altria, which owns Marlboro maker Philip Morris, and Reynolds American, which owns Lucky Strike and Camel, have also offered donations to Trump's $400 million White House ballroom project. Reynolds, the biggest producer of menthol cigarettes, also gave $10 million to the super PAC backing Trump in 2024.
According to The New York Times, executives for Altria and Reynolds were turning the screws on Trump over lunch at his golf club in Jupiter, Florida, in early May because they were "unhappy with the way the Food and Drug Administration was regulating their industry."
Trump interrupted the conversation to call up RFK Jr. and Mehmet Oz, the head of the Centers for Medicare and Medicaid Services (CMS), and complained to them about the FDA's regulation of e-cigarettes.
Within a week, the new policy had been enacted, and its leading opponent, Makary, was gone. He has since been replaced by Kyle Diamantas, whom the healthcare advocacy group Protect Our Care described as "a 30-something lawyer whose qualifications for such a critical public health role seem to begin and end at being Donald Trump Jr.’s 'hunting buddy.'”
"Donald Trump’s fury at FDA head Makary was motivated by gross political opportunism and fat checks from the big vape industry," said Jeremy Funk, the deputy director of Protect Our Care's Public Health Watch team. "Trump could not care less about the health consequences and costs of giving teenagers access to addictive flavored poison if it means his tobacco industry donors can make record profits."
While youth vaping is at a 10-year low, about 1.6 million middle and high school students were estimated to use vape products in the Centers for Disease Control and Prevention's 2024 National Youth Tobacco Survey. Nearly 90% of them said they used fruit and candy-flavored vapes.
Dr. Jerome Adams, a physician and professor at Purdue University, said in a post on social media that the rise of vaping has fueled a rebound in nicotine usage among college-aged adults.
"Youth combustible cigarette smoking was already at an all-time low and consistently dropping before vaping came on the scene. There is literally no reason to believe that the majority of young people who are now vaping would have otherwise been smoking combustible cigarettes," he said. "Amongst college-age and young adults, nicotine use is going back up to incredibly high rates—largely due to vaping."
The new policy enacted by the FDA has so far only authorized the sale of flavored products by one company, the Los Angeles-based Glas Inc., which will be allowed to sell vapes in flavors like mango and blueberry under names like "Gold" and "Sapphire."
The FDA sought to assuage fears of underage use by pointing to the Glas' digital age-verification system, which requires the product to be connected to the Bluetooth of a phone owned by a person over the age of 21. However, it is expected that, especially amid industry pressure, more companies will have their products approved soon.
Kayla Hancock, director of Protect Our Care’s Public Health Project, said that while Makary had a "terrible record" as FDA commissioner, having taken actions that slowed vaccine development and launched dubious, politically charged "reviews" of abortion pills long found to be safe, "apparently, it wasn’t terrible enough for Donald Trump."
"Hesitating to approve flavored vapes and not put American teens on a fast-track to lifelong addiction to harmful nicotine products is the bare minimum anyone could hope for from the Trump FDA," she said. "But that was a bridge too far for Donald Trump, who sees young people as disposable political pawns that he can appeal to with poison while lining the pockets of his big vape donors."
She said the ouster of Makary and his replacement with Diamantas "all but guarantees an FDA further consumed by chaos and driven by the wish lists of special interests that want profits put before public health."
Keep ReadingShow Less
Most Popular